Literature DB >> 11138839

Inhibition of IKs channels by HMR 1556.

H Gögelein1, A Brüggemann, U Gerlach, J Brendel, A E Busch.   

Abstract

Chromanol HMR 1556 [(3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl]-N-methylmethanesulfonamide], a novel inhibitor of the slow component of the delayed outward current in heart muscle cells (IKs), has been characterized in several in-vitro systems. mRNA encoding for the human protein minK was injected into Xenopus oocytes, leading to the expression of IKs channels. HMR 1556 inhibited this current half-maximally at a concentration of 120 nmol/l (IC50). Expression of the K+ channels Herg, Kv 1.5, Kv 1.3 and Kir2.1, and also the cationic current HCN2, were blocked little or not at all by 10 micromol/l HMR 1556. In isolated ventricular myocytes from the guinea pig the whole-cell patch-clamp method revealed inhibition of the IKs current with an IC50, of 34 nmol/l. Other current components, like IKr and IK1. were only slightly blocked at an HMR 1556 concentration of 10 micromol/l, whereas 10 micromol/l HMR 1556 inhibited the transient outward current I(to) and the sustained outward current I(sus) in rat ventricular myocytes by 25% and 36%, respectively. The L-type Ca2+ channel in guinea pig cardiomyocytes was blocked by 10 micromol/l HMR 1556 by 31%. Guinea pig right papillary muscles were investigated by the micropuncture technique at various pacing rates. In the frequency range of 0.5-7 Hz HMR 1556 (1 micromol/l) caused a prolongation of the action potential duration at 90% repolarization (APD90) by 19%-27%. In the presence of isoproterenol (10 micromol/l) the prolongation of the APD90 was more pronounced at low pacing rates (47% at 0.5 Hz and 35% at 1 Hz, compared with 25% at 7 Hz). The monophasic action potential was recorded in Langendorff-perfused guinea pig hearts. In spontaneously beating preparations, HMR 1556, at 0.1 micromol/l and 1 micromol/l, prolonged the MAPD90 by 3% and 10%, respectively, with no further prolongation at 10 micromol/l. The prolongation was much greater at low pacing rates [25% at 100 beats per min (bpm) and 13% at 150 bpm] than at fast pacing rates (9% at 350 bpm). The left ventricular pressure LVPmax was not affected at 1 micromol/l HMR 1556, but it decreased by 15% at 10 micromol/l. Other parameters, like the heart rate and coronary flow, were only slightly decreased at 1 micromol/l HMR 1556. In conclusion, HMR 1556 is a potent and selective inhibitor of the IKs current in guinea pig ventricular myocytes. The prolongation of the action potential duration is maintained at fast pacing rates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138839     DOI: 10.1007/s002100000284

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Endogenous KCNE subunits govern Kv2.1 K+ channel activation kinetics in Xenopus oocyte studies.

Authors:  Earl Gordon; Torsten K Roepke; Geoffrey W Abbott
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

Review 2.  Slow delayed rectifier potassium current (IKs) and the repolarization reserve.

Authors:  Norbert Jost; Julius Gy Papp; András Varró
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Blockade of IKs by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles.

Authors:  Petsy Pui-Sze So; Xu-Dong Hu; Peter H Backx; José Luis Puglisi; Paul Dorian
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

5.  Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.

Authors:  Courtney M Campbell; Jonathan D Campbell; Christopher H Thompson; Eleonora Savio Galimberti; Dawood Darbar; Carlos G Vanoye; Alfred L George
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-09-04

6.  Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanols.

Authors:  C Lerche; G Seebohm; C I Wagner; C R Scherer; L Dehmelt; I Abitbol; U Gerlach; J Brendel; B Attali; A E Busch
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.

Authors:  Ralph F Bosch; Alexander C Schneck; Saskia Csillag; Bernd Eigenberger; Uwe Gerlach; Joachim Brendel; Hans J Lang; Christian Mewis; Heinz Gögelein; Ludger Seipel; Volker Kühlkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-11       Impact factor: 3.000

Review 8.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

9.  Electrophysiological properties of human mesenchymal stem cells.

Authors:  Jürgen F Heubach; Eva M Graf; Judith Leutheuser; Manja Bock; Bartosz Balana; Ihor Zahanich; Torsten Christ; Sabine Boxberger; Erich Wettwer; Ursula Ravens
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

10.  Electrophysiological profile of propiverine--relationship to cardiac risk.

Authors:  Torsten Christ; Erich Wettwer; Melinda Wuest; Manfred Braeter; Frank Donath; Pascal Champeroux; Serge Richard; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.